IceCure Medical Ltd
General ticker "ICCM" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $59.7M (TTM average)
IceCure Medical Ltd does not follow the US Stock Market performance with the rate: -22.6%.
Estimated limits based on current volatility of 2.1%: low 0.69$, high 0.72$
Factors to consider:
- Total employees count: 55 as of 2021
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.60$, 1.60$]
- 2025-12-31 to 2026-12-31 estimated range: [0.57$, 1.53$]
Financial Metrics affecting the ICCM estimates:
- Positive: with PPE of -3.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -22.00 <= 0.33
- Negative: negative Net income
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 0.78 > -0.66
- Positive: 41.86 < Shareholder equity ratio, % of 54.87 <= 63.39
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term ICCM quotes
Long-term ICCM plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $3.08MM | $3.23MM | $3.29MM |
| Operating Expenses | $19.82MM | $18.80MM | $18.99MM |
| Operating Income | $-16.74MM | $-15.58MM | $-15.70MM |
| Non-Operating Income | $-0.24MM | $0.92MM | $0.38MM |
| Interest Expense | $0.24MM | $0.00MM | $0.00MM |
| R&D Expense | $9.12MM | $8.27MM | $7.10MM |
| Income(Loss) | $-16.98MM | $-14.65MM | $-15.32MM |
| Profit(Loss)* | $-17.22MM | $-14.65MM | $-15.32MM |
| Stockholders Equity | $25.42MM | $12.16MM | $6.90MM |
| Inventory | $2.86MM | $2.27MM | $1.99MM |
| Assets | $30.19MM | $16.41MM | $12.58MM |
| Operating Cash Flow | $-14.29MM | $-12.52MM | $-12.56MM |
| Capital expenditure | $0.89MM | $0.48MM | $0.07MM |
| Investing Cash Flow | $-0.89MM | $-0.71MM | $0.45MM |
| Financing Cash Flow | $13.58MM | $0.08MM | $9.19MM |
| Earnings Per Share** | $-0.47 | $-0.32 | $-0.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.